Clinical Trial: NCT06458712
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Status:
RECRUITINGPhase:
Phase 1| Lead Sponsor: | Duke Street Bio Ltd |
| Information Provided By: | Duke Street Bio Ltd |
| Last Update Posted: | 2026-09-02 |
Study Overview
Brief Summary
Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Official Title
Phase Ia/Ib Open Label, Multi-Centre Dose Escalation Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of DSB2455 as Monotherapy in Participants With Advanced Malignancies
Conditions
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Intervention / Treatment
- Drug: DSB2455
Other Study ID Numbers
- DSB2455-001
Start Date (Actual)
2024-11-21
Primary Completion Date (Estimated)
2028-08
Study Completion Date (Estimated)
2028-12
Enrollment (Estimated)
180
Study Type
Interventional
Phase
Phase 1
| Lead Sponsor: | Duke Street Bio Ltd |
| Information Provided By: | Duke Street Bio Ltd |
| Last Update Posted: | 2026-09-02 |
Study Overview
Brief Summary
Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Official Title
Phase Ia/Ib Open Label, Multi-Centre Dose Escalation Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of DSB2455 as Monotherapy in Participants With Advanced Malignancies
Conditions
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Intervention / Treatment
- Drug: DSB2455
Other Study ID Numbers
- DSB2455-001
Start Date (Actual)
2024-11-21
Primary Completion Date (Estimated)
2028-08
Study Completion Date (Estimated)
2028-12
Enrollment (Estimated)
180
Study Type
Interventional
Phase
Phase 1